The association of salvage intravesical therapy following BCG with pathologic outcomes and survival after radical cystectomy for patients with high-grade non-muscle invasive bladder cancer: A multi-institution analysis-Reference-Cited by-同舟云学术

The association of salvage intravesical therapy following BCG with pathologic outcomes and survival after radical cystectomy for patients with high-grade non-muscle invasive bladder cancer: A multi-institution analysis

Published:2021-07 Issue:7 Volume:39 Page:436.e1-436.e8
ISSN:1078-1439
Container-title:Urologic Oncology: Seminars and Original Investigations
language:en
Short-container-title:Urologic Oncology: Seminars and Original Investigations

Author:

Packiam Vignesh T.,Labbate Craig V.,Boorjian Stephen A.,Tarrell Robert,Cheville John C.,Avulova Svetlana,Sharma Vidit,Tsivian Matvey,Adamic Brittany,Mahmoud Mohammad,Werntz Ryan P.,Smith Norm D.,Karnes R. Jeffrey,Tollefson Matthew K.,Steinberg Gary D.,Frank Igor

Publisher

Elsevier BV

Subject

Urology,Oncology

Reference27 articles.

1. The treated natural history of high risk superficial bladder cancer: 15-year outcome;Cookson;J Urol,1997

2. NCCN guidelines insights: bladder cancer, version 5.2018;Flaig;J Natl Compr Cancer Netw JNCCN,2018

3. Treatment of non-metastatic muscle-invasive bladder cancer: AUA/ASCO/ASTRO/SUO guideline;Chang;J Urol,2017

4. European Association of Urology Guidelines on non-muscle-invasive bladder cancer (TaT1 and carcinoma in situ) - 2019 update;Babjuk;Eur Urol,2019

5. Risks and benefits of repeated courses of intravesical bacillus Calmette-guerin therapy for superficial bladder cancer;Catalona;J Urol,1987

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Long‐term outcomes of bladder‐sparing therapy vs radical cystectomy in BCG‐unresponsive non‐muscle‐invasive bladder cancer;BJU International;2024-08-25

2. Contemporary Treatment of NMIBC—Is It Time to Move on from BCG?;Journal of Clinical Medicine;2024-07-14

3. Transurethral resection of bladder tumor-based bladder preservation therapy for refractory high risk non-muscle invasive bladder cancer: Current landscape and future directions;Frontiers in Surgery;2023-04-12

4. Intravesical Therapy Compared to Radical Cystectomy Among Patients With Non-Muscle Invasive Bladder Cancer Requiring Additional Treatment After Induction BCG;Clinical Genitourinary Cancer;2022-12

5. A longitudinal single center analysis of T1HG bladder cancer: An 18 year experience;Urologic Oncology: Seminars and Original Investigations;2022-11